This company has been marked as potentially delisted and may not be actively trading. NYSE:RMED Ra Medical Systems (RMED) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Ra Medical Systems Stock (NYSE:RMED) 30 days 90 days 365 days Advanced Chart Get Ra Medical Systems alerts:Sign Up Key Stats Today's Range N/A50-Day Range$0.54▼$1.1052-Week Range N/AVolume77,500 shsAverage Volume197,480 shsMarket Capitalization$3.19 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Ra Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina. Read More Receive RMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ra Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address RMED Stock News HeadlinesSetPoint Medical Announces Late-Breaking Data from RESET-RA Study at ACR Convergence 2024November 19, 2024 | businesswire.comIntercorp Financial Servs (NYSE:IFS) Stock Quotes, Forecast and News SummaryOctober 20, 2024 | benzinga.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal. | Brownstone Research (Ad)Ra Medical Systems Inc (4RM.BE)August 18, 2024 | uk.finance.yahoo.comChina Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in ChinaAugust 6, 2024 | markets.businessinsider.comAlert1 Medical Alert System Review: What Experts Say (2024)February 20, 2024 | forbes.comRa Medical Systems Inc.February 15, 2024 | thestreet.comCatheter Precision Inc (VTAK)February 11, 2024 | investing.comSee More Headlines RMED Stock Analysis - Frequently Asked Questions How were Ra Medical Systems' earnings last quarter? Ra Medical Systems, Inc (NYSE:RMED) announced its earnings results on Monday, November, 15th. The company reported ($57.50) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($39.50) by $18.00. The business had revenue of $0.01 million for the quarter, compared to the consensus estimate of $0.70 million. When did Ra Medical Systems' stock split? Ra Medical Systems's stock reverse split before market open on Monday, October 3rd 2022.The 1-50 reverse split was announced on Monday, October 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. When did Ra Medical Systems IPO? Ra Medical Systems (RMED) raised $50 million in an initial public offering (IPO) on Thursday, September 27th 2018. The company issued 3,300,000 shares at a price of $14.00-$16.00 per share. Piper Jaffray and Cantor served as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers. What other stocks do shareholders of Ra Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ra Medical Systems investors own include Sangamo Therapeutics (SGMO), Meta Platforms (META), Corbus Pharmaceuticals (CRBP), NIO (NIO), Vaxart (VXRT), iBio (IBIO) and Pfizer (PFE). Company Calendar Last Earnings11/15/2021Today7/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSE:RMED CIK1716621 Webwww.ramed.com Phone(973) 691-2000FaxN/AEmployees14Year FoundedN/AProfitability EPS (Trailing Twelve Months)($92.36) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$26.86 million Net MarginsN/A Pretax Margin-97,518.88% Return on Equity-496.57% Return on Assets-344.49% Debt Debt-to-Equity RatioN/A Current Ratio2.86 Quick Ratio2.85 Sales & Book Value Annual Sales$10 thousand Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$4.29 per share Price / BookN/AMiscellaneous Outstanding Shares5,370,000Free Float4,368,000Market Cap$3.19 million OptionableNot Optionable Beta-0.03 10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NYSE:RMED) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ra Medical Systems, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Ra Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.